Editor(s):
(1) Dr. Takashi Ikeno, National Cancer Center Hospital East, Clinical Research Support Office, Japan.
Reviewers:
(1) Olabisi Promise Lawal, University of Benin, Nigeria.
(2) R. Hema Krishna, Amrita Sai Institute of Science and Technology, India.
(3) Sherifat Ozavize Enejiyon, Federal University of Technology, Nigeria.
(4) Bhumika Panchal, Parul University, India.
(5) Zahraa Isam Jameel, Al-Qasim Green University, Iraq.
(6) Shama Afroze Baig, Swami Shri Swaroopanand Saraswati Mahavidyalaya, India.
Additional Reviewers:
(1) Mahesh Recharla, USA.
(2) Pamela A. Marshall, Arizona State University, USA.
(3) Thualfakar Hayder Hasan, Jabir Ibn Hayyan University, Iraq.
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 5.58/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer Review Report_1 (Olabisi Promise Lawal, Nigeria) | File 1 | NA
Stage 2 | Peer Review Report_2 (R. Hema Krishna, India) | File 1 | NA
Stage 2 | Peer Review Report_3 (Sherifat Ozavize Enejiyon, Nigeria) | File 1 | File 2
Stage 2 | Peer Review Report_4 (Bhumika Panchal, India) | File 1 | NA
Stage 2 | Peer Review Report_5 (Zahraa Isam Jameel, Iraq) | File 1 | NA
Stage 2 | Peer Review Report_6 (Shama Afroze Baig, India) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 2 | Re-Review report_2_v1 | File 1 | NA
Stage 2 | Re-Review report_3_v1 (Declined/No response/NA) | NA | NA
Stage 3 | Comment_Editor_1_v1 | File 1 | NA